ITGAV and neoplasm: The tumor-specific alphavbeta3 integrin expression targeted dendritic cells, facilitating their ability to phagocytose viable therapy-resistant tumor cells, and thereby impaired their ability to cross-prime antigen-specific T lymphocyte, and it has been clearly demonstrated that the integrin plays a critical role in triggering invasive and metastatic activities of tumor cells.